Cardiology: 2 ════════════════════════════════════════════════════════════════════════════════════ ══════════════════════════
5-2.111 Correlate abnormal findings with clinical interpretation of the patient with a hypertensive emergency. (C-3)
5-2.112 5-2.113 5-2.114
5-2.115 5-2.116 5-2.117 5-2.118
Define the term "cardiogenic shock". (C-1) Describe the major systemic effects of reduced tissue perfusion caused by cardiogenic shock. (C-3) Explain the primary mechanisms by which the heart may compensate for a diminished cardiac output and describe their efficiency in cardiogenic shock. (C-3) Differentiate progressive stages of cardiogenic shock. (C-3) Identify the clinical criteria for cardiogenic shock. (C-1) Describe the characteristics of patients most likely to develop cardiogenic shock. (C-3) Describe the most commonly used pharmacological agents in the management of cardiogenic shock in
5-2.123 5-2.124 5-2.125 5-2.126 5-2.127 5-2.128
terms of therapeutic effects, dosages, routes of administration, side effects and toxic effects. (C-2) Correlate abnormal findings with clinical assessment of the patient in cardiogenic shock. (C-3) Identify the paramedic responsibilities associated with management of a patient in cardiogenic shock. (C- 2) Define the term "cardiac arrest". (C-1) Identify the characteristics of patient population at risk for developing cardiac arrest from cardiac causes. (C-1) Identify non-cardiac causes of cardiac arrest. (C-1) Describe the arrhythmias seen in cardiac arrest. (C-3) Identify the critical actions necessary in caring for the patient with cardiac arrest. (C-3) Explain how to confirm asystole using the 3-lead ECG. (C-1) Define the terms defibrillation and synchronized cardioversion. (C-1) Specify the methods of supporting the patient with a suspected ineffective implanted defibrillation device.
5-2.130 5-2.131 5-2.132 5-2.133
5-2.134 5-2.135 5-2.136 5-2.137 5-2.138 5-2.139 5-2.140 5-2.141
5-2.142 5-2.143 5-2.144 5-2.145 5-2.146 5-2.147
(C-2) Describe the most commonly used pharmacological agents in the managements of cardiac arrest in terms of therapeutic effects. (C-3) Identify resuscitation. (C-1) Identify circumstances and situations where resuscitation efforts would not be initiated. (C-1) Identify and list the inclusion and exclusion criteria for termination of resuscitation efforts. (C-1) Identify communication and documentation protocols with medical direction and law enforcement used for termination of resuscitation efforts. (C-1) Describe the incidence, morbidity and mortality of vascular disorders. (C-1) Describe the pathophysiology of vascular disorders. (C-1) List the traumatic and non-traumatic causes of vascular disorders. (C-1) Define the terms "aneurysm", "claudication" and "phlebitis". (C-1) Identify the peripheral arteries most commonly affected by occlusive disease. (C-1) Identify the major factors involved in the pathophysiology of aortic aneurysm. (C-1) Recognize the usual order of signs and symptoms that develop following peripheral artery occlusion. (C-3) Identify the clinical significance of claudication and presence of arterial bruits in a patient with peripheral vascular disorders. (C-3) Describe the clinical significance of unequal arterial blood pressure readings in the arms. (C-3) Recognize and describe the signs and symptoms of dissecting thoracic or abdominal aneurysm. (C-3) Describe the significant elements of the patient history in a patient with vascular disease. (C-2) Identify the hemodynamic effects of vascular disorders. (C-1) Identify the complications of vascular disorders. (C-1) Identify the Paramedic's responsibilities associated with management of patients with vascular disorders.
(C-2) 5-2.148 Develop, execute and evaluate a treatment plan based on the field impression for the patient with vascular disorders. (C-3)
────────────────────────── United States Department of Transportation National Highway Traffic Safety Administration Paramedic: National Standard Curriculum